Resverlogix/RVX Therapeutics

(SEDAR filing: 1 May 2013) Circular of Resverlogix Corp. ("Resverlogix") for spin-off of 1741273 Alberta Ltd. ("Newco"), the holder of the shares of RVX Therapeutics Inc. ("Therapeutics") (3792 K). Felesky
Summaries
Summary Under
Tax Topics - Public Transactions - Spin-Offs & Distributions - S. 86 spin-offs - Shares for Shares and Nominal Cash
Spin-off by Resverlogix of RVX Therapeutics and issuance of royalty preference shares
Overview

Pursuant to an Alberta Plan of Arrangement, Resverlogix is effectively spinning-off Newco to its shareholders. Newco will hold...

The text of this content is paywalled except for the first five days of each month. Subscribe or log in for unrestricted access.